Automation index

How much of a Mobile developer’s job can AI already do?

A layout and a store listing come earlier. It not crashing on a real phone do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

28%

AI can already do 28% of this job.

#92 / 623

Mobile developer

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Screens, API and offline state. Estimate No public source provides a precise figure. This is our estimate.	18%	52%	+9.4
Store review, crashlytics and ANRs. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Real device, the notch and fragmented Android. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
CI, tests and the week's release. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Product, the redesign and not breaking what people use. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
That it does not crash, and not ignoring the one-star. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		28%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

23%

#311 / 623

Radiation oncologist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Contouring, fractions and the dose plan. Estimate No public source provides a precise figure. This is our estimate.	16%	48%	+7.7
Clinic, the tumour and what can be irradiated. Estimate No public source provides a precise figure. This is our estimate.	18%	18%	+3.2
Simulation, immobilisation and the machine day. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Side effects, pauses and the patient who cannot take it. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Board, the surgeon and the medical oncologist. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Signing the plan and the dose that does not erase. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		23%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low